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The early symptoms of tularemia and plague, which are caused by Francisella tularensis
and Yersinia pestis infection, respectively, are common to other illnesses, resulting in
a low index of suspicion among clinicians. Moreover, because these diseases can be
treated only with antibiotics, rapid isolation of the bacteria and antibiotic susceptibility
testing (AST) are preferable. Blood cultures of patients may serve as a source for bacteria
isolation. However, due to the slow growth rates of F. tularensis and Y. pestis on solid
media, isolation by plating blood culture samples on proper agar plates may require
several days. Thus, improving the isolation procedure prior to antibiotic susceptibility
determination is a major clinically relevant need. In this study, we developed a rapid,
selective procedure for the isolation of F. tularensis and Y. pestis from blood cultures. We
examined drop-plating and plasma purification followed by immunomagnetic separation
(IMS) as alternative isolation methods. We determined that replacing the classical
isolation method with drop-plating is advantageous with respect to time at the expense
of specificity. Hence, we also examined isolation by IMS. Sub-localization of F. tularensis
within blood cultures of infected mice has revealed that the majority of the bacteria are
located within the extracellular fraction, in the plasma. Y. pestis also resides within the
plasma. Therefore, the plasma fraction was isolated from blood cultures and subjected
to an IMS procedure using polyclonal anti-F. tularensis live vaccine strain (LVS) or anti-
Y. pestis antibodies conjugated to 50-nm nano-beads. The time required to reach an
inoculum of sufficient bacteria for AST was shortest when using the plasma and IMSs for
both bacteria, saving up to 2 days of incubation for F. tularensis and 1 day for Y. pestis.
Our isolation procedure provides a proof of concept for the clinical relevance of rapid
isolation for AST from F. tularensis- and Y. pestis-infected patients.
Keywords: Francisella tularensis, Yersinia pestis, bacteremia, immunomagnetic separation, antibiotic
susceptibility, blood culture
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INTRODUCTION
Francisella tularensis is a gram-negative facultative intracellular
bacterium and the causative agent of tularemia (McCoy and
Chapin, 1912). As one of the most infectious pathogenic bacteria
known, it is classified by the CDC as a Tier 1 select agent1.
The disease is endemic in North America and Europe (Sjöstedt,
2007). Disease severity is influenced by the route of infection
and the bacterial subtype. The most severe form of tularemia
is caused by F. tularensis subsp. tularensis (type A), which is
found in North America (Olsufjev and Meshcheryakova, 1983;
Staples et al., 2006) whereas F. tularensis subsp. holarctica
(type B) is responsible for tularemia across the entire Northern
Hemisphere (Jusatz, 1961). F. tularensis live vaccine strain (LVS)
(Eigelsbach and Downs, 1961; Tigertt, 1962) is an attenuated
type B strain that does not cause disease in humans. LVS is
virulent in mice and is thus used in mouse models of the
disease (Sjöstedt, 2007). This vaccine has failed to achieve
licensing by regulatory authorities (Oyston, 2009). Six clinical
forms are observed: ulceroglandular, glandular, oculoglandular,
oropharyngeal, typhoid and pneumonic (Anda et al., 2007). The
latter is the most relevant in the context of bioterrorism because
symptoms develop 3–5 days post-exposure and mortality rates
reach 60% (Gill and Cunha, 1997).
Yersinia pestis is the causative agent of plague, a severe and
rapidly progressing disease. Due to its extreme lethality and
potential for aerosol transmission, Y. pestis is designated by the
CDC as a Tier 1 select agent1. Symptoms usually begin 1–8 days
post-exposure, depending on the route of exposure, infecting
strain, disease form (mainly bubonic, septicemic, or pneumonic),
dose of infection, and patient immunocompetence (Inglesby
et al., 2000). Bacteremia is frequently observed in patients and
infected animals (Butler et al., 1976; Perry and Fetherston, 1997).
High mortality rates are observed if treatment is not started
within 18–24 h after symptom onset (Pollitzer, 1954; Inglesby
et al., 2000).
Both tularemia and plague are treated with antibiotics;
no safe and efficient vaccines are currently available for
tularemia (Boisset et al., 2014) or plague (Pechous et al.,
2016). Unfortunately, highly fluoroquinolone-resistant mutants
of F. tularensis are easily and quickly obtained (Sutera et al.,
2014b), and some exhibit cross-resistance to other clinically
relevant antibiotic classes. Similarly, although most naturally
occurring Y. pestis strains are susceptible to recommended
antibiotics, plasmid-mediated single and multiple drug-resistant
strains have been isolated from patients (Galimand et al., 2006).
Due to the severity of infection by F. tularensis or Y. pestis
and the possibility of acquired resistance to recommended
antibiotics (either naturally or intentionally), treatment should
not rely solely on organism identification but should include
antimicrobial susceptibility testing (AST) of the bacteria isolated
from the patient. The conditions for performing AST for
F. tularensis or Y. pestis are defined by the CLSI guidelines (CLSI,
2015) and are based on the microdilution technique. Defined
concentrations of a bacterial suspension are inoculated into a
1https://www.selectagents.gov/selectagentsandtoxinslist.html
series of twofold dilutions of the tested antibiotic in a relevant
medium and incubated. The Minimal Inhibitory Concentration
(MIC) is defined as the lowest antibiotic concentration that
completely inhibits bacterial growth, as determined by the
unaided eye, following incubation for 24 h (Y. pestis) or 48 h
(F. tularensis).
Blood cultures are a major source of bacterial isolates for
AST. In the past, the isolation of F. tularensis from the
blood of infected patients has rarely been documented, possibly
due to the poor sensitivity of blood culturing systems or
the occurrence of bacteremia in the acute stages of infection
(Pittman et al., 1977). However, the number of reported tularemia
bacteremia cases has increased with the use of improved blood
culture isolation systems (Reary and Klotz, 1988), and in
recent years, more cases of tularemia bacteremia have been
reported in the literature (Haristoy et al., 2003; Sarria et al.,
2003; Khoury et al., 2005; Fritzsch and Splettstoesser, 2010;
Mohamed et al., 2012; Karagoz et al., 2013; Larssen et al.,
2014; Nirkhiwale et al., 2015; Ughetto et al., 2015; Briere et al.,
2016). Furthermore, studies have reported bacteremia in mice
infected intranasally with F. tularensis LVS 48 h post-infection
(Chiavolini et al., 2008). The bacteremic phase lasts up to
day 7 post-infection. In experimental respiratory tularemia in
African green monkeys and cynomolgus macaques, bacteremia
was detected 4 days post-infection (Glynn et al., 2015). The
clinical significance of F. tularensis bacteremia remains unknown;
however, bacteremia has been associated with a severe form
of the disease and with compromising pneumonia (Karagoz
et al., 2013). Bacteremia has also frequently been observed
in plague patients (Butler et al., 1976; Perry and Fetherston,
1997).
Although bacteremia has been identified in both diseases,
direct transfer of the blood culture into microdilution AST is
not feasible, mainly because blood components may interact
with either the bacteria or the antibiotics and influence the
test results. Moreover, blood components do not allow optical
quantification of the bacterial culture. Thus, bacteria isolation
by sub-culturing on agar media is a compulsory step that is
time-consuming due to the slow growth rates of these bacterial
species. For Y. pestis, 1–3 days are usually required for the blood
culture to be identified as positive, 2 days are required for colony
isolation, and another 24 h are required for AST (Perry and
Fetherston, 1997; Inglesby et al., 2000). Due to the slower growth
rates of F. tularensis, up to 7 days are required for positive blood
culture identification (Provenza et al., 1986; Haristoy et al., 2003),
2–3 days of incubation are required for the colony isolation step,
and 48 h are required for AST to determine proper MIC values.
In total, 6 days are usually required for Y. pestis, and 7 days or
more are required until F. tularensis blood cultures are identified
as positive and bacteria are quantified for AST (Fritzsch and
Splettstoesser, 2010; Karagoz et al., 2013; Ughetto et al., 2015). In
light of these time intervals, the development of rapid isolation
procedures is needed to ensure the clinical relevance of AST
results.
Previously, we reported that rapid separation of Y. pestis from
blood components can be achieved using a serum separation tube
(SST) (Steinberger-Levy et al., 2007). In another study, we have
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shown that an immunomagnetic separation (IMS) procedure
can be used to pre-enrich Y. pestis from environmental samples
(Zahavy et al., 2012). To reduce the time interval needed to
reach quantified F. tularensis and Y. pestis cultures suitable for
AST, we examined whether the application of an SST and IMS
facilitates isolation compared to classic plating or drop-plating
directly from blood cultures and whether these procedures can be
implemented for the isolation of F. tularensis and Y. pestis from
blood cultures.
We first characterized the bacteremic phase in F. tularensis-
infected mice and validated ex vivo F. tularensis spiking of
blood cultures as a mimic of infected blood cultures. Then,
we compared the efficacy of the three isolation procedures
for both bacterial species. The SST-IMS procedure enabled the
isolation of sufficient amounts of F. tularensis for AST within
the shortest time period for all blood cultures examined, ranging
from approximately 103 CFU/ml to greater than 109 CFU/ml.
Moreover, the SST-IMS method was also advantageous for
Y. pestis, which exhibits faster growth rates than F. tularensis,
suggesting that this method may be applicable to a wide range
of bacteria.
MATERIALS AND METHODS
Bacterial Strains, Media, Growth
Conditions, and Colony-Forming Unit
Determination
Francisella tularensis LVS (ATCC 29684) was grown on CHA
agar (5.1% cystine heart agar, 1% hemoglobin), (BD Difco,
Sparks, MD, USA) or in cation-adjusted Mueller-Hinton
broth (CAMHB) (BBL Difco, Sparks, MD, USA, #212322)
supplemented with 2% defined growth supplement (IsoVitaleX
Enrichment; BBL Difco, Sparks, MD, USA, #211876) and 3 µM
hematin (Sigma, Israel #3281) (termed HLMHI) at 37◦C. The
Y. pestis vaccine strain EV76 (Girard’s strain) (Ben-Gurion
and Shafferman, 1981) was grown on BHI-A (brain heart
infusion agar, BD Difco, Sparks, MD, USA, #241830) plates at
28◦C. Colony-forming unit (CFU) counts were determined by
plating 100 µl of serial 10-fold dilutions in sterile phosphate-
buffered saline (PBS, Biological Industries, Beth Haemek, Israel)
on CHA and BHI-A plates for F. tularensis and Y. pestis,
respectively. Drop-plating was performed by plating 10 µl
of serial 10-fold dilutions in triplicate on CHA and BHI-A
plates.
Animal Infection and Blood Collection
The animal experiment reported here was approved by the Israel
Institute for Biological Research animal care and use committee
and was conducted in accordance with the Animal Welfare
Act. F. tularensis LVS bacterial cultures were grown to mid-log
phase (optical density of 0.1–0.2 at 660 nm) at 37◦C in TSBC
(TSB Difco, Sparks, MD, USA, #211825 supplemented with 0.1%
cysteine). The bacteria were washed and re-suspended in PBS
at the desired concentration. BALB/c female mice (8–10 weeks
old, Charles River) were anesthetized with a mixture of 60 mg/kg
ketamine HCl and 10 mg/kg xylazine and infected intranasally
by application of 25 µl containing 105 CFU of F. tularensis LVS
(10LD50). Mice were monitored daily for clinical symptoms.
At the blood sampling time points, mice were anesthetized
with 150 mg/kg ketamine and 15 mg/kg xylazine and terminally
bled by cardiac puncture using a heparinized syringe. Blood
samples were pooled to a final volume of 2–5 ml.
Blood Cultures
Two to five milliliter of fresh infected blood or 10 ml of
human blood spiked with bacteria at defined concentrations was
incubated in BACTEC Plus Aerobic/F Culture vial (BD, Sparks,
MD, USA, #456005). The blood cultures were shaken at 150 rpm
at 37◦C in a New Brunswick Scientific C76 water bath for the
indicated time periods.
Fractionation of Blood Culture Samples
Blood culture samples were fractionated using SSTs (Vacuette
Z serum Sep. Clot activator, Greiner bio-one, Kremsmunster,
Austria #455071) to obtain the plasma fraction. The sample was
loaded into the SSTs and centrifuged for 10 min at 1700 g at
20◦C. For F. tularensis, the upper fraction was collected, and
the bacteria lying on the gel matrix were recovered and added
to the plasma fraction. For Y. pestis, the upper fraction was
discarded, and the bacteria lying on the gel matrix were recovered
with 1 ml of PBS. Mononuclear cells were purified from blood
culture samples using Vacutainer CPTs (cell preparation tubes)
NC (BD, Sparks, MD, USA, #362781) and Histopaque R©-1077
gradient (Sigma, Israel #10771) following the manufacturer’s
protocols.
Immunomagnetic Separation
Preparation of Antibody Nano-Bead Conjugates
A 50-µg quantity of polyclonal rabbit anti-F. tularensis
LVS serum (Mechaly et al., 2016) or 100 µg of polyclonal
rabbit anti-Y. pestis Kimberley53 (Zahavy et al., 2012)
were covalently linked to 10 mg of 50-nm magnetic beads
(fluidMAG-CMX 4106-1, Chemicell, Gmbh, Berlin, Germany)
as recommended by the supplier (protocol A11) using EDC (1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride)
(Sigma, Israel #PG82079) dissolved in MES buffer (0.1 M
2-(N-morpholino)ethanesulfonic acid), pH 5.
IMS Procedures
A capture solution containing 80 µl of the polyclonal antibody-
nanoparticle conjugate, 1% BSA, and 0.5% Tween 20 was added
to the plasma fraction containing the isolated bacteria from the
spiked blood cultures. The samples were incubated for 20 min
with gentle rotation at room temperature. LS separation columns
(Miltenyi Biotec. Inc, Auburn, CA, USA, #130-042-401) were
placed on the MidiMACS magnetic separator (Miltenyi Biotec
Inc, Auburn, CA, USA, #130-042-302) and preconditioned with
5 ml of PBS. Then, the sample was passed through the column.
The column was washed with 3 ml PBS and removed from
the magnet, and retained bacteria were washed off with 2 ml
of HLMHI for F. tularensis LVS or 1 ml of BHI for Y. pestis
EV76 pressed through the column with a piston. The IMS output
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was divided into aliquots of 100 µl in a 96-well microtiter
plate. Bacteria were grown to O.D.630 nm = 0.1 for F. tularensis,
which is equivalent to approximately 1–2 × 109 CFU/ml, and
O.D.630 nm = 0.035 for Y. pestis, which is equivalent to 2–3× 108
CFU/ml, using O.D.630 nm at time zero as a blank.
MIC Determination
Microdilution antibiotic susceptibility standard tests were
performed according to the CLSI guidelines for F. tularensis
and Y. pestis (CLSI, 2015). The recovered bacteria were diluted
to yield approximately 1–2 × 106 CFU/ml in HLMHI for
F. tularensis or approximately 106 CFU/ml in CAMHB for
Y. pestis, and 50 µl was inoculated in duplicate into 96-well
microtiter plates containing 50 µl of twofold serial dilutions of
each antimicrobial agent in the appropriate medium: doxycycline
(Sigma, Israel #D9891), ciprofloxacin infusion bag (Teva, Petah-
Tikva, Israel). The inoculum size was verified by plating 10-fold
dilutions on CHA or BHIA and incubation for 3 days at 37◦C
or 2 days at 28◦C for CFU counts of F. tularensis or Y. pestis,
respectively. The microtiter plates were incubated in a plate
reader (TECAN Infinite 200) for 48 h at 37◦C for F. tularensis
or 24 h at 28◦C for Y. pestis in ambient air, and O.D.630 nm was
read at 1-h intervals.
Etest assays for Y. pestis were conducted on MHA [Mueller
Hinton Agar (BBL Difco, Sparks, MD, USA, #225250)] and
on HIMA [MHA supplemented with 0.035% hemoglobin
(BBL Difco, Sparks, MD, USA, #212392)] and 2% defined
growth supplement (IsoVitaleX Enrichment; BBL Difco, Sparks,
MD, USA, #211876) for F. tularensis. Bacterial cultures with
the target turbidity of O.D.630 nm = 0.035 for Y. pestis
and O.D.630 nm = 0.1 for F. tularensis were used as direct
inocula by plating 0.1-ml aliquots on the appropriate agar
plate and uniformly spreading the bacterial lawn using a
Derigalski spatula. Etest strips of doxycycline and ciprofloxacin
(bioMerieux, Marcy-L′Etoile, France) were applied on the
plated agar and incubated for 24 h at 28◦C for Y. pestis or
48 h at 37◦C for F. tularensis. The MIC was determined by
reading the scale values on the strips at the intersection of
the growth inhibition zone, according to the manufacturers’
instructions.
FIGURE 1 | Bacteremia of F. tularensis LVS in the blood of infected mice. Mice were infected by the intranasal route with 105 CFU per mouse. On days 3–6
post-infection, groups of 5 mice were terminally bled, and the blood was pooled as one sample. Naïve mice served as controls. Blood samples were subjected to
clinical analysis, and disease development was indicated by measuring the levels of lymphocytes (A) and neutrophils (B). Blood samples were introduced into
BACTEC Plus Aerobic/F Culture vial. The levels of bacteria in the blood cultures at time = 0 h were determined by CFU counts and calculated as the in vivo
bacteremia levels on days 3, 4, and 5 post-infection (C). F. tularensis LVS multiplication levels within the blood cultures were determined by monitoring growth at
37◦C under moderate agitation (150 rpm) over 48 h. The red line (circle) represents the blood culture at day 3 post-infection, the blue line (square) represents the
blood culture at day 4 post-infection, and the black line (triangle) indicates the blood culture at day 5 post-infection (D). All CFU counts were performed in triplicate.
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RESULTS
Growth and Sub-localization of
F. tularensis in Blood Cultures of Infected
Mice
To develop a rapid isolation process, we first characterized
the growth of F. tularensis in blood cultures and the sub-
localization of the bacteria within the blood culture. BALB/c
mice were intranasally infected with 105 CFU of F. tularensis
LVS. Disease development was monitored by daily clinical and
physiological examination. Starting on day 3, blood samples
were drawn and pooled from 5 mice per day. Neutrophil and
lymphocyte counts of samples from days 4 through 6 were
compared to pooled blood samples form control naïve mice. The
reduction of lymphocyte levels and elevation of neutrophil levels
(Figures 1A,B) indicated an active disease. The pooled blood
was spiked into BACTEC Plus Aerobic/F Culture vials. The CFU
counts at time = 0 h in the spiked blood cultures reflected the
average in vivo bacteremic state. Bacteremia was evident at day
3 post-infection and its level increased with time, demonstrating
the involvement of bacteremia in disease progression within the
mice in the intranasal infection model. From the volume of
the BACTEC Plus Aerobic/F Culture vial content, we calculated
that the average concentration of the bacteria in the blood of
the infected mice was approximately 5 × 103, 5 × 104, and
5 × 106 CFU/ml on days 3, 4, and 5, respectively (Figure 1C).
Bacterial growth in the BACTEC Plus Aerobic/F Culture vials
were monitored over 48 h. The bacterial load increased by 4–6.5
orders of magnitude over 48 h, regardless of whether blood was
drawn at day 3, 4, or 5 (Figure 1D). These results suggested that
intranasal infection of mice with F. tularensis LVS recapitulated
the bacteremic phase of the disease and that the bacteria in
the blood drawn from the infected animals multiplied in the
BACTEC Plus Aerobic/F Culture vials.
Francisella tularensis has been reported to reside within blood
cells and in the extracellular fraction (Forestal et al., 2007; Yu
et al., 2008); thus, it was of interest to examine the distribution of
F. tularensis LVS within the blood cultures of the infected animals.
We employed the SST previously used to separate Y. pestis from
blood cultures (Steinberger-Levy et al., 2007) and separated the
plasma fraction from the cellular fraction. At all time points
examined, the majority of F. tularensis LVS was observed within
the plasma fraction (Table 1). Notably, F. tularensis LVS was
detected in the plasma fraction immediately after blood was
withdrawn from the mice, suggesting that the majority of the
bacteria in vivo were also residing in the plasma and not in the
intracellular fraction.
Growth and Sub-localization of
F. tularensis in Ex vivo Spiked Blood
Cultures
To avoid further infection of animals with F. tularensis LVS,
we performed ex vivo spiking human blood cultures with the
bacterium. To verify that F. tularensis in the ex vivo spiked
blood cultures also sub-localized in the extracellular fraction,
we measured the percentage of plasma-oriented bacteria at
various concentrations and time-points post spiking using the
SST tubes in a manner identical to that used for bacteria in
TABLE 1 | Localization and growth of F. tularensis LVS in blood cultures from infected mice∗.








3 0 1.8 × 103 ± 102 85
26 7.6 × 106 ± 2.5 × 106 100
48 2.6 × 109 ± 1.5 × 108 68
4 0 2 × 104 ± 1.4 × 103 88
26 2.7 × 106 ± 2.1 × 105 74
48 2.5 × 107 ± 2.8 × 106 96
5 0 2.5 × 105 ± 5.5 × 104 N.D.
24 1.3 × 108 ± 107 92
48 2.4 × 109 ± 2 × 108 96
∗Each sample contains pooled blood from five infected mice. ∗∗CFU counts were performed in triplicate, and the presented values are the average of the triplicate values.
The percent of bacteria in the extracellular fraction was calculated by dividing the CFU counts obtained after separating red blood cells from the plasma fraction using
SST by the CFU counts obtained from the blood culture before separation.
TABLE 2 | Levels of F. tularensis LVS in the mononuclear and the extracellular fractions of spiked naïve blood cultures grown for 1–2 days.
Concentration of bacteria (CFU/ml∗) Bacteria in mononuclear cells (%) Bacteria in the extracellular fraction (%)
Histopaque gradients CPT SST tubes
2.6 × 104 ± 2.6 × 103 10 14 95
2.4 × 105 ± 4.4 × 104 1.5 2.1 91
9 × 107 ± 1.4 × 107 16 3 72
∗Samples were plated in triplicate for CFU counts.
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the blood cultures originating from infected mice (Table 1).
Moreover, we quantified the percentage of cells associated with
F. tularensis LVS using both Histopaque gradients and CPT
tubes to ensure that the majority of the bacteria indeed resided
in the extracellular fraction and not in the cellular fraction
(Table 2). Similar to the sub-localization in blood cultures
from infected mice, the majority of F. tularensis LVS was
present in the extracellular fraction of the blood in the ex
vivo spiked blood cultures. These results confirm that ex vivo
spiking of blood cultures is a valid method for developing
procedures to improve the isolation of F. tularensis from blood
cultures.
Comparison of Methods for Rapid
Isolation of F. tularensis from Blood
Cultures
Agar Plating and Drop-Plating
The classic procedure to obtain a bacterial culture from a positive
blood culture is the isolation of individual colonies on agar
plates. These colonies are then used to prepare a standard
inoculum for use in AST. Due to the slow growth rates of
F. tularensis LVS strain, 3 days are required to reach colonies of
1–2 mm to yield sufficient bacteria for AST. Thus, we examined
whether drop-plating on CHA to contain the plated bacteria in
one spot would shorten the incubation time prior to AST of
blood cultures when F. tularensis is indicated clinically. For this
purpose, blood cultures were spiked with the F. tularensis LVS
strain and grown to high densities of approximately 109 CFU/ml.
The samples were 10-fold diluted, and drops of 10 µl were plated
on CHA plates and incubated for the indicated times at 37◦C
(Figure 2A). Following 24 h of incubation, F. tularensis LVS
drops at −3 log dilution of the original culture (ending with a
concentration of approximately 106 CFU/ml) yielded bacterial
growth that was sufficient to sample and prepare a standard
inoculum for AST assays. Notably, a high drop concentration
of 109 CFU/ml plated directly from the blood culture on CHA
inhibited the growth of F. tularensis LVS, probably due to
inhibitory factors within the blood culture. Thus, the diluted
sample consistently yielded better growth than the non-diluted
sample. The 10-fold dilution of the original sample may have
also diluted the inhibitory factors. Sufficient bacterial growth
FIGURE 2 | Drop-plating of F. tularensis blood culture samples. Blood cultures containing F. tularensis LVS were grown at 37◦C under moderate agitation
(150 rpm) to a concentration of approximately 109 CFU/ml. Both direct and tenfold dilutions were drop-plated as 10 µl in triplicate on CHA. The plates were
monitored, and growth was recorded at the indicated times (A). Blood cultures of various F. tularensis concentrations and their tenfold dilutions were drop-plated.
Growth of bacterial lawns and of individual colonies was monitored as a function of time at the indicated incubation time points (B).
Frontiers in Microbiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 312
fmicb-08-00312 February 25, 2017 Time: 15:46 # 7
Aloni-Grinstein et al. Rapid Bacteria Isolation from Blood Culture
required 48 h for a blood culture spot sample diluted to a
concentration of 104 CFU/ml and approximately 3 days when
the blood culture was diluted to 103 CFU/ml. To ensure that
the growth advantage obtained by drop-plating was not merely
due to the dilution of the bacteria, which may also dilute growth
inhibitors, we applied the drop-plating procedure with spiked
blood cultures of different concentrations (Figure 2B). The time
schedules obtained for the various blood cultures were within
the estimated time frame obtained by the serial dilution of the
high-density blood culture (Figure 2A). The estimated required
incubation times are summarized in Table 3. In summary, the
drop-plating technique may provide an advantage of 1–2 days
of incubation compared to classic plating if the blood culture is
pure and contains only F. tularensis without other contaminating
microorganisms.
Combination of SST and Immunomagnetic
Separation of F. tularensis LVS from Blood Cultures
The drop-plating technique reduced the incubation period
compared to classic plating, at the expense of a lack of specificity
and the potential for a genuine mixed population or fortuitous
contamination at blood withdrawal that may remain and be
co-cultured in the blood culture. Thus, we used an additional
isolation method based on specificity. Of the various available
methods, we adopted the SST-IMS procedure. Magnetic beads
with a diameter of 50 nm and coated with primary hyperimmune
rabbit anti-F. tularensis serum were used to selectively capture
and enrich F. tularensis LVS previously purified from blood
cultures by SST. The efficacy of the IMS procedure was at
least 60% of the inputs and, in most cases, ranged between
90 and 100%. The IMS outputs were recovered in HLMHI.
The growth curves indicated that recovery of the bacteria
from the SST-IMS procedure was concentration dependent.
We choose O.D.630 nm = 0.1 as an endpoint for recovery of
F. tularensis LVS because this O.D. reflected mid-log phase at
all concentrations examined (data not shown) and a bacterial
concentration of approximately 2 × 109 CFU/ml. Following the
establishment and application of the SST-IMS procedure, we
determined the correlation between blood culture concentration
and the time to obtain sufficient bacteria for downstream
AST procedures. To that end, F. tularensis LVS blood cultures
TABLE 3 | Incubation periods required to obtain 1- to 2-mm colonies of
F. tularensis LVS following drop-plating as a function of the initial bacterial
concentration.
Concentration of bacteria in
blood cultures (CFU/ml)∗









∗Samples were drop-platted in triplicate as described in Figure 2.
ranging from 2.4 × 103 CFU/ml to 2.7 × 109 CFU/ml were
subjected to the SST-IMS procedure. The time required to
reach the requested 0.1 O.D.630 nm is presented in Figure 3
and Table 4. Linear regression of log concentration versus
time yielded the prediction equation: Time (h) = −4.9891x
log (CFU/ml) + 46.1. At all blood culture concentrations
examined, the SST-IMS procedure was superior to drop-
plating with respect to time (Table 3 versus Table 4) and
specificity.
Isolation of Y. pestis EV76 from Blood
Cultures
We also examined whether SST-IMS is beneficial for timely
isolation of bacteria with a faster growth rate. We chose Y. pestis
because it is also designated as a Tier 1 select agent and the
time required for its isolation on agar is approximately 2 days.
Thus, a quicker isolation step would be clinically valuable. As
with F. tularensis LVS, we compared the time periods required
FIGURE 3 | Incubation time required to reach O.D.630 nm = 0.1 following
SST-IMS isolation of F. tularensis LVS from blood cultures. F. tularensis
LVS blood cultures at initial concentrations ranging from 2.4 × 103 CFU/ml to
2.7 × 109 CFU/ml were subjected to the SST-IMS procedure. A 100-µl
aliquot of the SST-IMS outputs from each blood culture was plated in 6
replicate in a 96-well microtiter plate. The microtiter plates were incubated in a
plate reader for 48 h at 37◦C in ambient air, and the absorbance at O.D.630 nm
was read at 1-h intervals until reaching 0.1 (see dotted line), representing
mid-log growth phase. The linear regression of log concentration versus time
yielded the following prediction equation: Time (h) = –5 × log (CFU/ml) + 46.
TABLE 4 | Incubation time required to reach O.D.630 nm = 0.1 following
SST-IMS isolation of F. tularensis LVS from blood cultures.
Concentration of bacteria in blood
cultures (CFU/ml)
Estimated time to reach sufficient
growth following SST-IMS (h)
≥108 4-6
107 5-10
2 × 106 ∼12
6.6 × 104 ∼18
104 ∼28
2.4 × 103 ∼33
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for classic plating for colony isolation, drop-plating, and SST-
IMS for the isolation of Y. pestis EV76 from spiked blood
cultures. Two incubation days are required for classic isolation to
obtain isolated colonies at any given bacterial concentration. No
bacteria were observed on BHIA plates 24 h after drop-plating a
blood culture of 2 × 103 CFU/ml (Figure 4). Colony formation
required 48 h following drop-plating (data not shown). However,
at concentrations of 2.5× 105 CFU/ml and greater, colonies were
observed after only 24 h of incubation (Figure 4). Thus, the drop-
plating technique may provide an advantage of a day compared
to classic plating, although at the expense of selectivity. Based
on our previous work (Steinberger-Levy et al., 2007), Y. pestis
EV76 was isolated from the plasma fraction of the blood culture
sample using SST and subjected to an IMS procedure using 50-
nm magnetic beads coated with primary hyperimmune rabbit
anti-Y. pestis serum. The efficacy of the IMS procedure was
at least 60% of the inputs and ranged between 90 and 100%
in most cases. Bacteria were recovered in BHI medium until
reaching O.D.630 nm = 0.035, reflecting mid-log growth (data
not shown) and a bacterial concentration of 2–3 × 108 CFU/ml.
The time required to reach O.D.630 nm = 0.035 as a function
of bacterial concentration is presented in Figure 5. Linear
regression of log concentration versus time yielded the following
prediction equation: Time (h)=−6.1926× log (CFU/ml)+ 52.3.
Consistent with the results obtained for F. tularensis LVS, SST-
IMS was superior to the classic and drop-plating procedures for
Y. pestis EV76 (Table 5). Our results suggest that the SST-IMS
procedure is an efficient and prompt procedure that may be used
for rapid isolation of the Tier 1 agents F. tularensis and Y. pestis.
MIC Determination
The recommended antibiotics for post-exposure prophylaxis of
F. tularensis and Y. pestis are ciprofloxacin and doxycycline
(Inglesby et al., 2000; Dennis et al., 2001). As a proof of
concept of the validity of our isolation procedure, we performed
FIGURE 4 | Drop-plating of Y. pestis blood culture samples. Y. pestis
EV76 blood cultures were grown at 37◦C under moderate agitation (150 rpm)
to 2.6 × 106, 2.5 × 105, and 2 × 103 CFU/ml. Both direct and 10-fold
dilutions were drop-plated in triplicate as 10-µl aliquots on BHIA. The plates
were incubated at 28◦C, and growth was recorded 24 h post plating.
FIGURE 5 | Incubation time required to reach O.D.630 nm = 0.035
following SST-IMS of Y. pestis blood cultures. Y. pestis EV76 blood
cultures at various initial concentrations were subjected to the SST-IMS
procedure. Aliquots of 100 µl of the SST-IMS outputs from each blood culture
were plated in 6 replicates in microtiter plates. The microtiter plates were
incubated in a plate reader for 48 h at 28◦C in ambient air, and the
absorbance at O.D.630 nm was read at 1-h intervals until reaching 0.035.
Linear regression of log concentration versus time yielded the following
prediction equation: Time (h) = –6.1926x + 52.311.
TABLE 5 | Comparison of the time schedules for the isolation of Y. pestis
EV76 from blood cultures by classic plating, drop-plating and SST-IMS.
Concentration of bacteria in
blood cultures (CFU/ml)
Incubation time (h)
Classic plating Drop-plating∗ SST-IMS
107 ∼48 ∼24 ∼8
2.6 × 106 ∼48 ∼24 ∼13
2.5 × 105 ∼48 ∼24 ∼20
2 × 104 ∼48 ∼24 ∼31
∗Samples were drop-plated in triplicate.
AST of these recommended antibiotics. F. tularensis cultures in
HLMHI that reached O.D.630 nm = 0.1 (reflecting approximately
2 × 109 CFU/ml) and Y. pestis cultures in BHI that reached
O.D.630 nm = 0.035 (reflecting approximately 2–3× 108 CFU/ml)
were diluted as required by the CLSI to yield approximately
5 × 105–2 × 106 CFU/ml and inoculated into 96-well microtiter
plates in a final volume of 100 µl/well. Microdilution tests were
performed as described in the Section “Materials and Methods.”
The MIC was defined at the end of the incubation time (24 h for
Y. pestis and 48 h for F. tularensis) as the lowest concentration
that reduced growth to less than 10% of the O.D.630 nm of the
growth control, and a lack of visible growth was verified by the
unaided eye. MIC values are presented as a range and include
all values obtained in repetitions (n = 3) (Table 6). F. tularensis
LVS displayed the expected ‘susceptible’ category as indicated
by MICs of 0.016 µg/ml for ciprofloxacin, ≤0.5 µg/ml (the
endpoint for the susceptible category for this bacterium), and
0.06–0.125µg/ml for doxycycline,≤4µg/ml. Similar MIC ranges
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were obtained by the Etest method, which does not appear
to have an advantage over microdilution with respect to the
required incubation period but may prove useful for low levels
of contamination in blood cultures. Similarly, microdilution tests
(n = 3) of Y. pestis EV76 revealed MIC values of 0.5–1 µg/ml
for doxycycline and 0.016–0.032 µg/ml for ciprofloxacin. In
the Etests, the MIC values were similar and ranged from 0.5
to 0.75 µg/ml for doxycycline and 0.023 to 0.032 µg/ml for
ciprofloxacin. All MIC results were in complete agreement with
assays conducted using standard inoculum and test conditions.
These MIC results indicate that the SST-IMS procedure is suitable
for the rapid isolation of F. tularensis and Y. pestis for AST.
DISCUSSION
The symptoms of tularemia include fever, headache, chills, sore
throat, and body aches (Dennis et al., 2001). These symptoms
are common to other illnesses, resulting in a low index of
suspicion for tularemia among clinicians. Tularemia may be
TABLE 6 | Minimal Inhibitory Concentration (MIC) determination.
Doxycycline (µg/ml) Ciprofloxacin (µg/ml)
Microdilution Etest Microdilution Etest
F. tularensis LVS 0.06–0.125 0.125-0.19 0.016 0.008-0.023
Y. pestis EV76 0.5–1 0.5–0.75 0.016–0.032 0.023–0.032
considered an option only after exclusion of more common
infectious diseases. Consequently, some tularemia patients
may be treated with broad-range antibiotics without actual
identification of F. tularensis as the causative agent (Fritzsch and
Splettstoesser, 2010). Thus, isolation of the bacteria may benefit
both identification and, more importantly, AST characterization
to assure proper antibiotic treatment. In recent years, efforts
have been made to facilitate AST procedures for tularemia and
develop new approaches to determine susceptibility toward both
the extracellular and intracellular forms of the bacteria (Sutera
et al., 2014a; Aloni-Grinstein et al., 2015).
FIGURE 6 | Time required to reach the required inoculum of bacteria for AST using the different isolation methods. F. tularensis LVS (A). Y. pestis
EV76 (B).
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Blood cultures are a potential clinical source of bacteria
from the patient. Moreover, determination of bacteremia
may have an impact on the clinical outcome and medical
consideration toward the patient. For years, bacteremia was
rarely identified, but new culture systems have improved
growth and detection, and bacteremia is now reported more
widely. Indeed, we observed the development of bacteremia
in our mouse model during the progression of the disease
(Figure 1) and determined that the majority of the bacteria
were in the plasma fraction rather than the cellular fraction
(Table 1). In an attempt to mimic blood cultures of infected
animals, we ex vivo spiked F. tularensis LVS into BACTEC Plus
Aerobic/F Culture vials containing naïve blood and showed
that the bacteria reside mainly in the plasma fraction in spiked
blood cultures as well (Table 2). This behavior allowed us to
develop a rapid isolation procedure for bacteria from blood
cultures.
The isolation of F. tularensis from blood cultures is a tedious
procedure. Blood culture components negatively influence both
PCR identification procedures (Regan et al., 2012) and the
prerequisite quantification step and inoculum size adjustment
using absorbance determination for standard AST (CLSI, 2015).
Thus, sub-culturing is required prior to AST. Due to the slow
growth rates of F. tularensis and Y. pestis, sub-culturing for
isolation is time-consuming. Here, we aimed to bypass the sub-
culturing isolation step by either drop-plating or by physical
separation from red blood cells and an IMS procedure for
transferring the bacteria from the plasma to rich liquid medium.
Indeed, drop-plating blood cultures with F. tularensis LVS with
at least 106 CFU/ml (Figure 2) and Y. pestis with at least 105
CFU/ml (Figure 4) yielded sufficient bacteria by 24 h. However,
small percentages of these samples may be contaminated
because no selective procedure was applied to distinguish
F. tularensis or Y. pestis from potential contaminating bacteria
due to either natural infection or contamination during the
blood withdrawal procedure (Weinstein, 2003). This drawback
highlights the advantage of IMS, which enriches bacteria by
selective immunoseparation. The presence of F. tularensis
LVS bacteria primarily in the extracellular fraction in blood
cultures from infected animals allowed us to obtain the
majority of the bacteria from the blood culture by a simple
step using SSTs before IMS purification. IMS separates the
bacteria from the blood components and growth-inhibitory
substances present in the blood culture and components that
mask proper quantification by turbidity measurement. The
recovered concentrated bacteria in enrichment media permit
rapid growth to the essential load necessary for use as an
inoculum for various AST methods. Indeed, we have shown
that the isolation of bacteria by the SST-IMS procedure
permits proper MIC determination by microdilution within a
shorter time than the conventional isolation method. Moreover,
we have shown that this procedure is superior to classic
plating for both F. tularensis and Y. pestis (Figure 6), which
represent bacteria with different growth rates. These different
bacteria validate the universality of the method for other
bacteremia-causing bacteria. In summary, we have shown
that the SST-IMS procedure is a rapid, specific procedure
for the isolation of bacteria from positive blood cultures.
The SST-IMS procedure allows AST for both F. tularensis
and Y. pestis to be performed within a significantly shorter
time period after the blood culture is identified as positive
for these pathogens (Tables 3–5), thus shortening the time
necessary to conduct AST for proper antibiotic treatment
determination.
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